Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company has three commercial products and a fourth in development, which are improved formulations of marketed drugs. The Company acquires products that fulfill unmet medical needs, manage the required clinical development and regulatory approval process, and market those products either directly or through partners. Its core capabilities include clinical and regulatory affairs, product licensing, supply chain management, and marketing and sales. The Company has regulatory marketing approval in the United States and Canada for all three of its original products and has completed eight marketing partnerships.